Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

IMNM holding history

Immunome Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMNM overviewAll 13F holders of IMNMFull Q2 2026 holdings

Shares (Q2 2026)
328,493
Value
$6.96M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IMNM by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026328,493$6.96M<0.1%−104,419−24.1%ReducedHolders
Q1 2026432,912$9.47M<0.1%+125,718+40.9%AddedHolders
Q4 2025307,194$6.60M<0.1%−276,748−47.4%ReducedHolders
Q3 2025583,942$6.84M<0.1%+158,027+37.1%AddedHolders
Q2 2025425,915$3.96M<0.1%+81,864+23.8%AddedHolders
Q1 2025344,051$2.32M<0.1%+155,854+82.8%AddedHolders
Q4 2024188,197$2.00M<0.1%+108,957+137.5%AddedHolders
Q3 202479,240$1.16M<0.1%+1,557+2.0%AddedHolders
Q2 202477,683$940.0K<0.1%+53,032+215.1%AddedHolders
Q1 202424,651$608.4K<0.1%+24,651NewHolders
Q4 20230$00.0%−14−100.0%Sold outHolders
Q3 202314$117<0.1%−1,044−98.7%ReducedHolders
Q2 20231,058$8.37K<0.1%+1,044+7,457.1%AddedHolders
Q1 202314$70<0.1%−460−97.0%ReducedHolders
Q4 2022474$1.05K<0.1%−14,797−96.9%ReducedHolders
Q3 202215,271$68.0K<0.1%+13,943+1,049.9%AddedHolders
Q2 20221,328$4.00K<0.1%+1,208+1,006.7%AddedHolders
Q1 2022120$1.00K<0.1%−2,371−95.2%ReducedHolders
Q4 20212,491$32.0K<0.1%+2,477+17,692.9%AddedHolders
Q3 202114$00.0%−1,356−99.0%ReducedHolders
Q2 20211,370$24.0K<0.1%+922+205.8%AddedHolders
Q1 2021448$15.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.